PDL
Top 10 drugs in PDL incident reports
In its latest practice update, PDL lists the medicines most commonly associated with incident reports it receives… and some should be no surprise It is no surprise that the top …
Tips for avoiding S8 pitfalls
In its latest practice update, PDL has offered information on Schedule 8 medicines management Schedule 8 medicines, in particular opioids, are often involved in notifications to PDL. An Australian Institute …
Lapsed PI and notice of relevant events
In this latest practice alert, PDL reviews lapsed PI renewal and other ‘relevant events’ that pharmacists and pharmacy students need to notify Ahpra about Lapsed Professional Indemnity insurance arrangements – …
Reflecting on ConPharm 2022
In this latest PDL Practice Alert, two representatives share some common questions from accredited pharmacists and their responses PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and …
Vaccine-related incident reports on the rise
PDL has issued a practice alert in which it gives advice on dealing with vaccine requests, particularly given growing demand for flu jabs The recent surge in demand for influenza …
Vaccinating for winter
What you need to know about vaccinating against influenza and providing COVID-19 winter doses and boosters As winter approaches, pharmacies will be very busy providing vaccinations against influenza (flu) as …
The what, how and why of PI insurance
Ensuring you are covered for incidents such as dispensing errors, vaccinations, incorrect clinical advice, statutory and/or regulatory complaints Professional Indemnity Insurance (PI insurance or PII) may seem like an uninteresting …
Practice alert: Spikevax for kids
Now that the Moderna Spikevax vaccine has been approved for children 6-11 years, PDL has offered members some advice The ATAGI approval of Moderna Spikevax for the primary vaccination of …
Private fentanyl: be alert
PDL has reminded pharmacists that every private prescription presented for potent opioids should be treated with high suspicion. In its latest practice alert, PDL has highlighted the issue of private fentanyl and other …
Managing the risk
PDL outlines preparation and risk management considerations for the paediatric Pfizer vaccine The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from …
The next phase
PDL outlines what pharmacists need to know for the next phase of the COVID-19 vaccination service The PDL Professional Officers have noted a recent reduction in the number of calls …
Vaccination administration, have you got it RIGHT?
In its latest practice alert, PDL offers a helpful checklist when vaccinating patients against COVID-19 PDL recognises the extraordinary efforts that pharmacists have made to provide COVID-19 vaccines to more …